Stevens-Johnson Syndrome - Symptoms, Causes, Treatment & Prevention

```html

Overview

Stevens-Johnson Syndrome (SJS) is a severe, potentially life-threatening condition affecting the skin and mucous membranes. Named after doctors Stevens and Johnson who first described it in 1962, SJS is characterized by an intense skin rash and blistering, often triggered by medications or infections. It primarily impacts adults but can occur in children, with higher prevalence rates in certain ethnic groups, including Caucasians and Asians. According to the CDC, SJS affects approximately 1-2 people per million annually in the United States.

While rare, SJS has a high mortality rate—around 5-15%—if untreated. Early recognition and medical intervention are critical. This guide provides actionable information about symptoms, causes, and treatment options, emphasizing safety and when to seek emergency care.

Symptoms

SJS symptoms typically progress in stages, starting with mild flu-like signs before escalating. Below is a comprehensive list of symptoms:

Early Symptoms (24-48 hours)

• Fever and chills: High-grade fever may present first, indicating an immune response.
• Sore throat or mouth sores: Initial mucous membrane involvement often affects the oral cavity.
• Fatigue: Unusual tiredness or weakness is common.

Acute Rash (1-3 days)

• Red or purplish patches: Develop on skin, often with a target-like appearance.
• Blistering: Blisters form and rupture, exposing raw skin.
• Pain: The rash can be intensely painful, especially when touched.

Mucosal Involvement

• Eye inflammation: Conjunctivitis or dry eyes may occur, risking vision damage.
• Sore throat or swollen lips: Mucus membranes in the throat and lips blister and peel.
• Nasal and ear issues: Mucosal damage in the nose or ears is frequent.

Systemic Signs

• Dehydration: Caused by fluid loss from blisters or difficulty swallowing.
• Low white blood cell count: Indicates compromised immunity.

These symptoms require immediate medical attention. The National Institute of Allergy and Infectious Diseases (NIAID) notes that facial edema (swelling) and breathing difficulties signal a medical emergency.

Causes and Risk Factors

SJS is primarily caused by an adverse drug reaction, but infections and autoimmune disorders can also trigger it. Below are key factors:

Medication Triggers

• Antibiotics: Sulfonamides (e.g., sulfamethoxazole), penicillin
• NSAIDs: Celecoxib, ibuprofen
• Anticonvulsants: Carbamazepine, phenytoin
• Allopurinol: Used for gout

Most cases occur within 2-6 weeks of starting a new drug. The Mayo Clinic advises patients to report prior allergic reactions to healthcare providers.

Infections as Triggers

• HIV/AIDS (weakened immunity increases susceptibility)
• Herpes viruses (e.g., Epstein-Barr virus)
• Bacterial infections (e.g., pneumonia)

Population-Specific Risks

• Ethnicity: Higher prevalence in Caucasians and Asians (CDC data from 2020).
• Age: Most common in adults 30-60 years old.
• Previous Drug Reactions: Prior SJS or Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (TEN) recurrence

Smokers and individuals with genetic predispositions (e.g., HLA-B*5801 allele) may also be at increased risk.

Diagnosis

Diagnosing SJS relies on clinical evaluation and confirmatory tests. The World Health Organization (WHO) states that a skin biopsy is often essential for definitive diagnosis.

Clinical Assessment

• Evaluation of rash progression and mucosal involvement
• Assessment of systemic symptoms (e.g., fever, lethargy)

Tests

1. Skin biopsy: Identifies epidermal damage patterns typical of SJS (NIH study, 2018).
2. Blood tests: Rule out infections or autoimmune conditions.
3. Drug rechallenge: Sometimes used in research settings to confirm drug causation.

Early diagnosis is critical. The Cleveland Clinic warns that delayed treatment increases mortality risk by 30%. Seek care immediately if symptoms align with SJS.

Treatment Options

Treatment focuses on stopping the causative agent and supporting recovery. The American Academy of Dermatology (AAD) emphasizes multidisciplinary care.

Immediate Actions

1. Discontinue offending drugs: Stop all medications immediately if a trigger is identified.
2. Hospitalization: Most patients require intensive care for life-threatening complications.

Supportive Care

• Fluid and electrolyte management: Prevent dehydration from vomiting or diarrhea.
• Antibiotics: Used only if bacterial infections occur.
• Pain relief: Topical anesthetics or oral medications like gabapentin.

Long-Term Recovery

• Skin rehabilitation: Moisturizers and silicone-based dressings prevent scarring.
• Ophthalmology care: Corneal transplant may be needed if eyes are damaged.

Newer therapies, including corticosteroids and immunosuppressants, are being studied (Journal of the American Academy of Dermatology, 2022). However, no cure exists; outcomes depend on prompt intervention.

Living with Stevens-Johnson Syndrome

Recovery involves physical and emotional adjustments. Daily management tips include:

• Skin care: Keep affected areas clean but avoid irritating products.
• Avoid triggers: Consult a pharmacist about drug alternatives.
• Follow-up: Regular dermatology and ophthalmology appointments

Mental health support is crucial. Symptoms like depression or anxiety are common, per a 2021 WHO report. Encourage patients to join support groups.

Prevention

While not all cases are preventable, risks can be reduced:

• Medical communication: Inform providers of past drug reactions or allergies.
• Genetic testing: Identify HLA-B*5801 allele in at-risk populations before starting certain medications.
• Alternative drugs: Use drugs with lower SJS risk (e.g., allopurinol alternatives for gout).

The CDC recommends annual flu shots to reduce infection-triggered cases. Education remains key in prevention.

Complications

Untreated SJS can lead to catastrophic outcomes:

• Toxic Epidermal Necrolysis (TEN): 90% of SJS cases progress to TEN, which has an 80-90% mortality rate (CDC, 2023).
• Sepsis: Blisters create entry points for bacterial infections.
• Permanent damage: Scarring, blindness, or difficulty breathing

Immediate care is non-negotiable. Early treatment can reduce mortality to under 5% (NIH longitudinal study).

When to Seek Emergency Care

Contact emergency services immediately if you experience:

• Rapidly spreading rash or fever above 103°F
• Severe pain, eye swelling, or vision changes
• Difficulty breathing or swallowing
• Signs of infection (pus, fever worsening)

This condition can deteriorate within hours. Delaying care increases death risk by up to 50% (Cleveland Clinic emergency guidelines).

```